© 2019 IPHARMA

  • Facebook Social Icon
  • LinkedIn Social Icon
  • YouTube Social  Icon
  • Instagram Social Icon

On September, 28th, we will discuss the Rules of granting subsidies for drug development as part of "Pharma 2020" program

26.09.2016

On September, 28th at 11:00 am, we will hold a  webinar on the "Rules of granting subsidies to implement the projects on drug development under the "Pharma 2020" Federal Target Program".

 

Register to the webinar

 

The webinar is devoted to reimbursement of expenses related to the next-in-class projects realization in accordance with the Resolution № 1503 of 30.12.2015 and changes in the Rule of granting subsidies  № 1045 of 10.01.2015.

 

Under the Resolution № 1503 of 30.12.2015, the subsidies are granted for the generics development and for improving the analogues of innovative drugs.

 

What will you learn from the webinar?

• For whom these programs are

• Who can participate

• Costs that can be covered with the funds borrowed

• How to write an Application, practical tips

• And much more…

 

For whom?

For pharmaceutical and biotech companies, participants in the clinical trial market. 

 

Hosts:

Natalia Lebedeva, IPHARMA Business Development Manager

Vyacheslav Rogov, IPHARMA Legal Counsel

 

To participate you must register with filling in the Form.

 

Prior to the webinar, the listeners can ask questions related to the topic, which they would like to discuss.

On the day of the webinar, you will receive an email invitation with a link to the broadcast confirming your registration.

 

 

 

Please reload

Недавние посты
Please reload

Архив
Please reload